Company profile: Pharmaleads
1.1 - Company Overview
Company description
- Provider of analgesic drug development focused on DENKIs, a new class of analgesics derived from highly potent and specific enkephalinase inhibitors, aiming to deliver improved pain relief for patients with severe chronic and acute pain without the side effects associated with other classes of analgesics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pharmaleads
Akome Biotech
HQ: Canada
Website
- Description: Provider of psychedelic-based pharmaceuticals for rare diseases and mental disorders, targeting treatments for cluster headaches, Alzheimer’s disease, and depression, serving patients suffering from stroke and neurological illnesses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Akome Biotech company profile →
Sio Gene Therapies
HQ: United States
Website
- Description: Provider of clinical-stage biopharmaceutical solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sio Gene Therapies company profile →
Stellate
HQ: Canada
Website
- Description: Provider of networking, database, recording, review, and analysis systems for electrical activity from the brain, serving EEG laboratories, epilepsy monitoring units, sleep laboratories, and intensive care units; engaged in the development, design, and manufacture of products for brain activity recording and analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Stellate company profile →
Saegis Pharma
HQ: United States
Website
- Description: Provider of medicines in development for behavioral disorders, with a pipeline of treatments for central nervous system diseases involving cognitive dysfunction, including Alzheimer’s disease, mild cognitive impairment, and attention deficit hyperactivity disorder.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Saegis Pharma company profile →
Muna Therapeutics
HQ: Denmark
Website
- Description: Provider of biopharmaceutical therapies and discovery platforms to slow or stop neurodegenerative diseases including Alzheimer’s, Parkinson’s, Frontotemporal Dementia, and Multiple Sclerosis. Programs include TREM2 agonism for early-stage Alzheimer’s, Kv1.3 blockade for Parkinson’s and MS, and MiND-MAP, an all-in-human target discovery and validation platform using single cell spatial multi-omics in patient samples.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Muna Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pharmaleads
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pharmaleads
2.2 - Growth funds investing in similar companies to Pharmaleads
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pharmaleads
4.2 - Public trading comparable groups for Pharmaleads
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →